While genetic mutations of certain components of the Wnt/β-catenin pathway, such as APC and CTNNB1, are significant contributing factors for colorectal cancers, they are typically not the predominate mechanism associated with many other types of cancer such as breast and prostate cancers. This evidence concerns the gene CTNNB1 and prostate carcinoma.